Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury

Open Access

Peer-reviewed

Research Article

Gerardo M. Castillo ,

* E-mail: gcastillo@pharmain.com (GMC); alyubimov1@gmail.com (AVL)

Affiliation PharmaIN Corp., Bothell, Washington, United States of America
⨯
Akiko Nishimoto-Ashfield,

Affiliation PharmaIN Corp., Bothell, Washington, United States of America
⨯
Cynthia C. Jones,

Affiliation PharmaIN Corp., Bothell, Washington, United States of America
⨯
Kasim K. Kabirov,

Affiliation Toxicology Research Laboratory, Department of Pharmacology, University of Illinois at Chicago, Chicago, IL, United States of America
⨯
Alexander Zakharov,

Affiliation Toxicology Research Laboratory, Department of Pharmacology, University of Illinois at Chicago, Chicago, IL, United States of America
⨯
Alexander V. Lyubimov

* E-mail: gcastillo@pharmain.com (GMC); alyubimov1@gmail.com (AVL)

Affiliation Toxicology Research Laboratory, Department of Pharmacology, University of Illinois at Chicago, Chicago, IL, United States of America
⨯

Reader Comments (0)

Gastrointestinal tract
Is the Subject Area "Gastrointestinal tract" applicable to this article?

Thanks for your feedback.
Jejunum
Is the Subject Area "Jejunum" applicable to this article?

Thanks for your feedback.
Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
Colon
Is the Subject Area "Colon" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Fibroblast growth factor
Is the Subject Area "Fibroblast growth factor" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Radiation therapy
Is the Subject Area "Radiation therapy" applicable to this article?

Thanks for your feedback.